Related Experiment Videos

Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation

T A Lee1, P J Farnham

  • 1Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison 53706, USA.

Oncogene
|May 24, 2000
PubMed

Insights

E2F1 transcription factor expression significantly inhibits NIH3T3 cell growth and transformation. However, some cells with specific alterations can overcome this E2F1-mediated growth inhibition.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The E2F family of transcription factors plays a crucial role in cell cycle regulation.
  • Upregulation of E2F has been linked to neoplastic phenotypes, but its role as a tumor suppressor is under investigation.

Purpose of the Study:

  • To investigate the tumor suppressor properties of E2F1.
  • To determine the effect of exogenous E2F expression on cell growth and transformation in NIH3T3 cells.

Main Methods:

  • Utilized a tissue culture model system (NIH3T3 cells).
  • Assessed colony formation and focus formation assays.
  • Investigated the role of E2F DNA binding activity and protein interaction domains.

Main Results:

  • Exogenous E2F expression led to an 80% decrease in NIH3T3 colony formation and inhibited Ras-mediated focus formation.
  • E2F's inhibitory effect was dependent on DNA binding but not specific protein domains.
  • Exogenous E2F also inhibited the growth of pre-transformed NIH3T3 cells (Ras or Neu).
  • Early transfection resulted in significant cell population loss, with a subset of cells eventually unaffected.

Conclusions:

  • E2F1 exhibits tumor suppressor properties by inhibiting cell growth and transformation.
  • Cells that acquire dominant alterations can evade E2F-mediated growth inhibition.
  • Increased E2F activity may only be tolerated in cells with specific, dominant genetic changes.

Related Concept Videos